 |
SINGAPORE, April 30, 2019 /PRNewswire/ -- Mundipharma CEO, Raman Singh, has been ranked among the most world's most powerful Business Captains on a list of the Top 100 medical and pharmaceutical sector leaders by UK-based industry publication, the Medicine Maker.
2019 is the fifth year in succession that Mr Singh has featured on the Power List.
The Medicine Maker's Power List identifies the top 100 individuals with the most significant impact on the world of medicine across four categories, each featuring 25 leaders, under 'Masters of the Bench', 'Industry Influencers', 'Business Captains' and 'Champions of Change'.
Judged by a panel of industry experts, the list features top executives, scientists and other professionals from leading pharmaceutical and healthcare companies as well as a range of academic and civil society institutions.
Mr Singh said, "I'm honoured and humbled to be named among the leading Business Captains, especially at a time when our industry is experiencing such rapid transformation.
"In this technology-driven landscape, leaders must initiate and navigate change, and provide clear and strong direction. The key to this is highly-talented people. My focus is ensuring Mundipharma is an agile, innovative, future-focussed organisation that is making a difference in patients' lives, and I'm proud to be surrounded by people that share this ambition."
The Medicine Maker Power List 2019 and its four sub-categories were published in the magazine's April 2019 edition.
About Mundipharma
Mundipharma is a network of independent associated companies which are privately owned entities covering pharmaceutical markets in Asia-Pacific, Latin America, the Middle East and Africa. The headquarters for these territories is in Singapore. Mundipharma is a prime example of an organization that consistently delivers high-quality medicines while standing by the values it represents. Its mission is to alleviate the suffering of patients and to substantially improve their quality of life. Mundipharma is dedicated to bringing to patients the benefit of novel treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare.
For more information please visit: www.mundipharma.com.sg
Logo - http://photos.prnasia.com/prnh/20150302/8521501264LOGO
